The downregulation of let-7a-5p in serum has been shown to predict lymph node metastasis and prognosis in colorectal cancer patients [286], whereas the RKIP/let-7 pathway metastasis signature has been demonstrated to predict a high risk of metastasis in breast cancer with higher accuracy than the individual genes [287]. This evidence concerns the gene PEBP1 and breast carcinoma.